/Investor DB

Calculus Capital Ltd. — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Resurrect Bioresurrect.bioinFeb 2026 · $8.1M

Resurrect Bio develops more durable crop disease resistance by engineering plant immune receptors, combining plant molecular immunology, computational biology, AI, and high-throughput screening.

AgTechAI & Machine LearningBiotechLondon, GB

Cian Duggan(CEO & Co-Founder)inTolga Bozkurt(Co-Founder)inSophien Kamoun(Co-Founder)in

Co-investorsFuture Planet CapitalGrowth Science VenturesSynBioVenUK Innovation & Science Seed FundAgFunderPymwymic

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.